Vir Biotechnology
VIR
VIR
196 hedge funds and large institutions have $656M invested in Vir Biotechnology in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 77 increasing their positions, 68 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $783M → $656M (-$127M)
46% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 39
86% less call options, than puts
Call options by funds: $1.28M | Put options by funds: $8.95M
Holders
196
Holding in Top 10
2
Calls
$1.28M
Puts
$8.95M
Top Buyers
| 1 | +$9.38M | |
| 2 | +$8.13M | |
| 3 | +$4.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.97M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.49M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$6.64M | |
| 3 | -$3.86M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.6M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$3.44M |